AVITA Medical, Inc. (RCEL) SEC filings

RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$15.63−0.57 (-3.52%)

Close on Nov 13, 2026Market cap $483.39MP/E –Yield –

SEC filings

40 of AVITA Medical's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Nov 13, 2026	Nov 13, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Nov 2, 2026	Nov 2, 2026	SEC EDGAR
Current report	8-K	Aug 5, 2026	Aug 11, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jun 5, 2026	Jun 8, 2026	SEC EDGAR
Current report	8-K	Jun 3, 2026	Jun 4, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 14, 2026	SEC EDGAR
Current report	8-K	May 14, 2026	May 14, 2026	SEC EDGAR
Current report	8-K	Apr 30, 2026	May 1, 2026	SEC EDGAR
Proxy statement	DEF 14A	Apr 22, 2026	Apr 22, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 12, 2026	SEC EDGAR
Current report	8-K	Feb 12, 2026	Feb 12, 2026	SEC EDGAR
Current report	8-K	Jan 13, 2026	Jan 13, 2026	SEC EDGAR
Current report	8-K	Jan 1, 2026	Jan 5, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Nov 5, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Oct 16, 2025	Oct 17, 2025	SEC EDGAR
Current report	8-K	Aug 12, 2025	Aug 18, 2025	SEC EDGAR
Current report	8-K	Aug 12, 2025	Aug 12, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 8, 2025	SEC EDGAR
Current report	8-K	Aug 7, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Aug 6, 2025	Aug 6, 2025	SEC EDGAR
Current report	8-K	Jun 4, 2025	Jun 5, 2025	SEC EDGAR
Current report	8-K	May 15, 2025	May 15, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 8, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Proxy statement	DEF 14A	Apr 22, 2025	Apr 22, 2025	SEC EDGAR
Current report	8-K	Mar 17, 2025	Mar 17, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 13, 2025	SEC EDGAR
Current report	8-K	Feb 13, 2025	Feb 13, 2025	SEC EDGAR
Current report	8-K	Jan 7, 2025	Jan 7, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 7, 2024	SEC EDGAR
Current report	8-K	Nov 7, 2024	Nov 7, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 8, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 8, 2024	SEC EDGAR
Current report	8-K	Jul 31, 2024	Jul 31, 2024	SEC EDGAR
Current report	8-K	Jun 28, 2024	Jul 1, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in AVITA Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Jun 30, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RCEL.

Compare: RCEL vs TELA · RCEL vs MDXG · RCEL vs APYX · RCEL vs PDEX · RCEL vs ANIK

Revenue growth17.0% · median 9.4%

Gross margin82.4% · median 63.4%

Operating margin-33.9% · median -5.5%

Net margin-42.7% · median -6.3%

Company	Revenue	Growth
MDXG	$303.73M	-22.8%
ANIK	$123.43M	+9.4%
RCEL	$84.68M	+17.0%
PDEX	$79.58M	+13.3%
TELA	$78.18M	+1.5%
APYX	$59.57M	+24.4%

Company

Next earnings (est.): Feb 11, 2027, during market hours
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 226
Auditor: GRANT THORNTON LLP
SEC CIK: 1762303

Advertisement
300 × 250

See a number that looks wrong?